Intrinsic Value of S&P & Nasdaq Contact Us

Centene Corporation CNC NYSE

NYSE • Healthcare • Medical - Healthcare Plans • US • USD

SharesGrow Score
55/100
1/7 Pass
SharesGrow Intrinsic Value
$1,904.59
+5013%
Analyst Price Target
$44.90
+20.5%

Centene Corporation (CNC) generated $5.09B in operating cash flow for fiscal year 2025. After capital expenditures of $767M, free cash flow was $4.32B.

Free cash flow margin was 2.2% of revenue. Cash conversion ratio was -0.76x, suggesting some earnings are non-cash.

The company returned $475M in share buybacks to shareholders during the period.

Criteria supported by this page:

  • HEALTH (50/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
  • MOAT (56/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
  • INCOME (10/100) — Cash conversion ratio was -0.76x suggests some earnings are non-cash items

Overall SharesGrow Score: 55/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
55/100
SG Score
View full scorecard →
VALUE
86/100
Price-to-Earnings & upside
→ Valuation
~
FUTURE
58/100
Analyst consensus
→ Forecast
~
PAST
75/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
Proven by this page
~
MOAT
56/100
Proven by this page
~
GROWTH
48/100
→ Income
INCOME
10/100
→ Income
Centene Corporation Cash Flow History
Metric TTM FY2025 FY2024 FY2023 FY2022
Operating Cash Flow $5.09B$5.09B$154M$8.05B$6.26B
Capital Expenditure $-767M$-767M$-644M$-799M$-1B
Free Cash Flow $4.32B$4.32B$-490M$7.25B$5.26B
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message